Making Sense of MS Research

Summaries of independent,
high-quality research about multiple sclerosis treatments

Interferons for Primary Progressive MS

What is this treatment?

Interferons are considered a ‘first line’ treatment of multiple sclerosis and are commonly prescribed for people with relapsing-remitting forms of MS.  They are not usually prescribed for people with primary progressive MS.  In Australia, the Therapeutic Goods Administration (TGA) does not recommend that interferons should be used in the treatment of primary progressive MS.

As the diagnosis of Primary progressive MS (as distinct from relapsing forms of MS) can take some time, people with PPMS may already be taking interferons when they are diagnosed with this kind of MS.